Net Income (TTM) Chart

View Net Income (TTM) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -199.00M
March 31, 2026 -242.00M
December 31, 2025 -232.00M
September 30, 2025 36.00M
June 30, 2025 434.00M
March 31, 2025 373.00M
December 31, 2024 338.00M
September 30, 2024 205.00M
June 30, 2024 -1.255B
March 31, 2024 -1.302B
December 31, 2023 -1.231B
September 30, 2023 -1.144B
June 30, 2023 -113.00M
March 31, 2023 -26.00M
December 31, 2022 -78.00M
September 30, 2022 -128.00M
Date Value
June 30, 2022 -167.00M
March 31, 2022 -367.00M
December 31, 2021 -479.00M
September 30, 2021 -697.80M
June 30, 2021 -728.80M
March 31, 2021 -572.00M
December 31, 2020 -560.10M
September 30, 2020 -246.80M
June 30, 2020 -101.80M
March 31, 2020 -12.70M
December 31, 2019 67.90M
September 30, 2019 93.80M
June 30, 2019 144.00M
March 31, 2019 45.30M
December 31, 2018 86.50M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Zoetis, Inc. 2.616B
Eli Lilly & Co. 26.71B
ANI Pharmaceuticals, Inc. 99.95M
EyePoint, Inc. -306.64M
Amylyx Pharmaceuticals, Inc. -152.09M